Blue Shield of California reduced its oversight of the state’s COVID-19 vaccine distribution in July. It now has a limited role in the program as California’s vaccine needs have changed, according to the report.
The insurer’s $15 million contract to oversee California’s vaccine rollout was riddled with controversy, as it proved difficult to get county and provider buy-in. While California Gov. Gavin Newsom and Blue Shield of California leadership have said the insurer’s oversight sped up distribution and helped saved lives, results from the rollout remain unclear, according to the Times.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
